Abeona Therapeutics Inc vs NIO Inc. — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while NIO Inc. trades at $4.57 (market cap $11.59B). The key difference: NIO Inc. is far larger — about 27.5× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals.
| ABEO | NIO | |
|---|---|---|
Market Cap | $421.19M | $11.59B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.45 | $7.89 |
52-Week Low | $4.17 | $4.44 |
Enterprise Value | $276.10M | $10.82B |
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →